A new report from the Bipartisan Policy Center examines the complex regulatory landscape for health AI tools that operate outside the jurisdiction of the FDA. As AI becomes more integrated into healthcare, the report highlights the challenges and opportunities for responsible innovation amidst a patchwork of federal rules and state laws.
This article presents an AI readiness assessment framework tailored for the pharmaceutical industry, emphasizing the importance of aligning AI initiatives with regulatory standards and ethical practices. It highlights the critical need for transparency, data integrity, and accountability in adopting AI technologies to ensure patient safety and scientific integrity throughout the drug development lifecycle.
The article discusses the integration of artificial intelligence (AI) in oncology, highlighting its potential applications throughout a patient’s cancer journey, from clinical trial matching to treatment planning. It emphasizes the need for responsible AI governance frameworks tailored specifically to oncology to ensure quality assurance and address the unique challenges in the field.
The article discusses the integration of artificial intelligence (AI) in oncology, highlighting its potential applications throughout a patient’s cancer journey, from clinical trial matching to treatment planning. It emphasizes the need for responsible AI governance frameworks tailored specifically to oncology to ensure quality assurance and address the unique challenges in the field.
This article presents an AI readiness assessment framework tailored for the pharmaceutical industry, emphasizing the importance of aligning AI initiatives with regulatory standards and ethical practices. It highlights the critical need for transparency, data integrity, and accountability in adopting AI technologies to ensure patient safety and scientific integrity throughout the drug development lifecycle.
Texas has enacted comprehensive AI governance laws, including the Texas Responsible Artificial Intelligence Governance Act (TRAIGA) and Senate Bill 1188, which establish a framework for responsible AI use, particularly in the healthcare sector. These laws mandate transparency in AI usage and prohibit discriminatory practices, ensuring that patients are informed about AI involvement in their care.
New Jersey legislators have advanced a bill that would prohibit the use of artificial intelligence as a licensed mental health professional, citing risks associated with AI therapy. The measure aims to protect consumers and addresses the growing reliance on AI chatbots for mental health support amidst a shortage of mental health workers.
As artificial intelligence (AI) revolutionizes healthcare, it brings both significant opportunities and risks, necessitating the establishment of robust governance, risk management, and compliance (GRC) frameworks. Without these, organizations risk ethical dilemmas, regulatory violations, and potential harm to patients.
Nevada’s unemployment agency has implemented an artificial intelligence tool to prescreen claims, significantly accelerating the approval process by 30 times. The tool boasts a 99.99% accuracy rate, while still involving human analysts to make final decisions on each claim.
The article discusses the growing demand for aged care services due to an increasing elderly population and the potential role of artificial intelligence in addressing this need. It emphasizes the importance of establishing proper AI governance frameworks to ensure safe and responsible implementation within the aged care industry.